HOW PSYCHEDELIC MEDICINE RESEARCH WILL IMPACT END OF LIFE CARE

March 21, 2024

End of life care and psychedelic medicine research - how end of life care may be impacted in the coming years.

Target Audience

  • Allied Health Professionals
  • Nurses
  • Nurse Practitioners
  • Physicians

Learning Objectives

  • Discussing the possible implications of current FDA clinical trials into psychedelic medicines and psychedelic assisted therapy with terminally diagnosed patients and their families; 
  • Listing both potential benefits and limits of potential psychedelic interventions and therapy for symptoms commonly experienced in the end-of-life patient group. 
  • Naming and explaining the building blocks required to develop an ethical psychedelic practice. 
  • Identifying ways to improve hospice effectiveness with symptoms of existential distress, anxiety and depression - both pharmacologically and nonpharmacologically, including psycho-social-spiritual interventions and support
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 0.10 IACET CEU
  • 1.00 JA Credit - AH
Registration Opens: 
03/21/2024
Registration Expires: 
03/21/2025
Activity Starts: 
03/21/2024 - 8:30am EDT
Activity Ends: 
03/21/2024 - 10:00am EDT
Add to calendar: 
Rating: 
0
Durham, NC 27705
United States

Glenn Withrow, MD, ABFM, PAT

Perry Pike, MDiv, MA, BCC, PAT

Darlene Bankhardt, BSN, RN, CNMML

Christie Smith, LCSW

Lindsey Jackson, MSN,BSBA, FNP-C, RN, CCM

David Fisher

AMA PRA Category 1 Credit(s)

ANCC

Attendance

IACET CEU

JA Credit - AH

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 0.10 IACET CEU
  • 1.00 JA Credit - AH
Please login or register to take this course.